Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (603456) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Zhejiang Jiuzhou Pharmaceutical Co., Ltd.

Why is Zhejiang Jiuzhou Pharmaceutical Co., Ltd. ?

With ROE of 7.55%, it has a very attractive valuation with a 1.86 Price to Book Value

Over the past year, while the stock has generated a return of 22.51%, its profits have fallen by -25.7%
At the current price, the company has a high dividend yield of 2.8

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Zhejiang Jiuzhou Pharmaceutical Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Zhejiang Jiuzhou Pharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Zhejiang Jiuzhou Pharmaceutical Co., Ltd.

25.29%

0.65

38.22%

China Shanghai Composite

15.19%

1.01

14.58%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

19.44%

EBIT Growth (5y)

17.22%

EBIT to Interest (avg)

38.95

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.23

Sales to Capital Employed (avg)

0.56

Tax Ratio

18.17%

Dividend Payout Ratio

44.44%

Pledged Shares

Institutional Holding

ROCE (avg)

15.80%

ROE (avg)

11.35%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.86

EV to EBIT

18.45

EV to EBITDA

11.85

EV to Capital Employed

2.15

EV to Sales

2.70

PEG Ratio

Dividend Yield

2.77%

ROCE (Latest)

11.62%

ROE (Latest)

7.55%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

14What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 1,519.92 MM

INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

DIVIDEND PAYOUT RATIO(Y)

Highest at 63.98%

RAW MATERIAL COST(Y)

Fallen by -2.64% (YoY

DIVIDEND PER SHARE(HY)

Highest at CNY 3.57

OPERATING PROFIT(Q)

Highest at CNY 437.38 MM

OPERATING PROFIT MARGIN(Q)

Highest at 32.07 %

PRE-TAX PROFIT(Q)

Highest at CNY 341.2 MM

NET PROFIT(Q)

Highest at CNY 275.63 MM

EPS(Q)

Highest at CNY 0.31

-1What is not working for the Company

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.57%

Here's what is working for Zhejiang Jiuzhou Pharmaceutical Co., Ltd.

Operating Cash Flow

Highest at CNY 1,519.92 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Operating Profit

Highest at CNY 437.38 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Operating Profit Margin

Highest at 32.07 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

Highest at CNY 341.2 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Pre-Tax Profit

At CNY 341.2 MM has Grown at 76.8%

over average net sales of the previous four periods of CNY 192.98 MM

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 275.63 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Net Profit

At CNY 275.63 MM has Grown at 77.96%

over average net sales of the previous four periods of CNY 154.89 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.31

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Dividend per share

Highest at CNY 3.57

in the last five years

MOJO Watch

Company is distributing higher dividend from profits generated

DPS (CNY)

Dividend Payout Ratio

Highest at 63.98%

in the last five years

MOJO Watch

Company is distributing higher proportion of profits generated as dividend

DPR (%)

Raw Material Cost

Fallen by -2.64% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Zhejiang Jiuzhou Pharmaceutical Co., Ltd.

Debtors Turnover Ratio

Lowest at 3.57%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio